Saturday, October 04, 2025 11:56:46 AM
It's the ORC penny stock mentality. It's only $0.25 and if it only goes to $0.50 they've doubled their money!?!?!?!?! But the success rate of OTC biotechs is dismal.
I follow another zombie biotech, CYDY. And after several years of demonstrating the stock fraud acts of the CEO, the CEO was indicted and convicted and is doing time. But they are peddling their OTC penny stock continually diluting shareholders and continually teasing their shareholders on the incredible promise of their now almost off patent drug. Again NO BP will touch an OTC biotech drug. And these OTC biotechs have no capability to commercialize a drug if they actually got to approval. Just look at NWBO with only effectively 4 employees.
I follow another zombie biotech, CYDY. And after several years of demonstrating the stock fraud acts of the CEO, the CEO was indicted and convicted and is doing time. But they are peddling their OTC penny stock continually diluting shareholders and continually teasing their shareholders on the incredible promise of their now almost off patent drug. Again NO BP will touch an OTC biotech drug. And these OTC biotechs have no capability to commercialize a drug if they actually got to approval. Just look at NWBO with only effectively 4 employees.
Recent NWBO News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
